Last reviewed · How we verify
Usual insulin treatment
Insulin works by stimulating glucose uptake in cells, thereby lowering blood glucose levels.
Insulin works by stimulating glucose uptake in cells, thereby lowering blood glucose levels. Used for Type 1 diabetes, Type 2 diabetes.
At a glance
| Generic name | Usual insulin treatment |
|---|---|
| Sponsor | Centre Hospitalier Universitaire Dijon |
| Drug class | insulin |
| Target | insulin receptor |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
Insulin binds to the insulin receptor on the surface of cells, triggering a cascade of intracellular signaling events that ultimately lead to the uptake of glucose from the bloodstream into cells. This process is essential for maintaining normal blood glucose levels and preventing hyperglycemia.
Approved indications
- Type 1 diabetes
- Type 2 diabetes
Common side effects
- Hypoglycemia
- Weight gain
- Allergic reactions
Key clinical trials
- Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes (NA)
- Gestational Diabetes and Pharmacotherapy (GAP) (PHASE4)
- Effects of Cofrogliptin on Beta-Cell Function in LADA Patients (NA)
- Intervention for Children With Type 1 Diabetes Targeting Gut Microbes (NA)
- Empagliflozin Adjunctive Therapy in Bipolar Depression (NA)
- Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery (NA)
- Closed-loop in Adults With Type 2 Diabetes (NA)
- Isoleucine Addition Treatment Effects in a Controlled Diet Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Usual insulin treatment CI brief — competitive landscape report
- Usual insulin treatment updates RSS · CI watch RSS
- Centre Hospitalier Universitaire Dijon portfolio CI